Lucía López‐Anglada

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

Bruno Paiva, Noemí Puig, María‐Teresa Cedena et al. · Journal of Clinical Oncology · 2019 · 276 citations · Full text

Medicine, Hematology, Oncology +17

Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma

Laura Rosiñol, Albert Oriol, Rafael Ríos et al. · Blood · 2019 · 216 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients

Jorge Labrador, Lucía López‐Anglada, Estefanía Pérez‐López et al. · Haematologica · 2012 · 90 citations · Full text

Medicine, Hematology, Surgery +17

Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality

Joaquín Martínez‐López, Bruno Paiva, Lucía López‐Anglada et al. · Blood · 2015 · 63 citations · Full text

Medicine, Hematology, Oncology +12

<i>P53</i> deletion may drive the clinical evolution and treatment response in multiple myeloma

Lucía López‐Anglada, Norma C. Gutiérrez, María‐Victoria Mateos et al. · European Journal Of Haematology · 2009 · 53 citations · Full text

Medicine, Hematology, Oncology +15